未登录

R

Reda G. Yousef

al-azhar university

H指数:17

被引数:1,058

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

New theobromine-derived EGFR inhibitor: integrated in silico studies and in vitro evaluations

新型可可碱衍生的EGFR抑制剂：集成体外研究和体外评价

Journal of Molecular Structure

IF4.7

2026-08-050

PRE

Development of novel furan-based VEGFR-2 inhibitors and apoptotic inducers for colorectal cancer

新型呋喃基VEGFR-2抑制剂和促凋亡诱导剂的研发及其在结直肠癌中的应用

FUTURE MEDICINAL CHEMISTRY

IF3.4

2025-11-010

PRE

Integrated Computational and Experimental Discovery of a Promising Xanthine Derivative with Anticancer Potential Targeting EGFR

集成计算与实验方法发现一种靶向EGFR且具有抗癌潜力的黄嘌呤衍生物

CURRENT CANCER DRUG TARGETS

IF3.5

2025-10-010

PRE

VEGFR-2-Targeted Semisynthetic Theobromine Derivative: A Computer-Aided Drug Design (CADD) Approach

Journal of Computational Biophysics and Chemistry

IF2.3

2025-10-010

PRE

Discovery of new thieno[2,3-d]pyrimidine-based dual VEGFR-2 and EGFR inhibitors for enhanced therapeutic efficacy in breast cancer

新型噻吩[2,3-d]嘧啶类双靶点VEGFR-2和EGFR抑制剂的发现，以增强乳腺癌的治疗效果

JOURNAL OF MOLECULAR STRUCTURE

IF4.7

2025-06-030

PRE

Anti-breast cancer potential of thieno-pyrimidine derivatives as VEGFR-2 inhibitors

FUTURE MEDICINAL CHEMISTRY

IF3.4

2025-03-010

PRE

Design and synthesis of new nicotinamides as immunomodulatory VEGFR-2 inhibitors and apoptosis inducers

FUTURE MEDICINAL CHEMISTRY

IF3.4

2024-11-141

OA

Biological and computational assessment of new synthesized nicotinamides as potential immunomodulatory VEGFR-2 inhibitors

JOURNAL OF MOLECULAR STRUCTURE

IF4.7

2024-06-014

PRE

New Theobromine Apoptotic Analogue with Anticancer Potential Targeting the EGFR Protein: Computational and In Vitro Studies

IF4.3

2024-03-272

OAAI

Computer-assisted drug discovery (CADD) of an anti-cancer derivative of the theobromine alkaloid inhibiting VEGFR-2

SAUDI PHARMACEUTICAL JOURNAL

IF3.4

2023-12-019

OAAI

New theobromine derivative as apoptotic anti-triple-negative breast cancer targeting EGFR protein: CADD story

JOURNAL OF MOLECULAR STRUCTURE

IF4.7

2023-12-0130

PRE

New apoptotic anti-triple-negative breast cancer theobromine derivative inhibiting EGFRWT and EGFRT790M: in silico and in vitro evaluation

MOLECULAR DIVERSITY

IF3.8

2023-05-109

PRE

A New Anticancer Semisynthetic Theobromine Derivative Targeting EGFR Protein: CADDD Study

IF3.4

2023-01-0919

OAAI

(E)-N-(3-(1-(2-(4-(2,2,2-Trifluoroacetamido)benzoyl)hydrazono)ethyl)phenyl)nicotinamide: A Novel Pyridine Derivative for Inhibiting Vascular Endothelial Growth Factor Receptor-2: Synthesis, Computational, and Anticancer Studies

IF4.6

2022-11-0938

OAAI

Discovery of New VEGFR-2 Inhibitors: Design, Synthesis, Anti-Proliferative Evaluation, Docking, and MD Simulation Studies

IF4.6

2022-09-2125

OAAI

New Anticancer Theobromine Derivative Targeting EGFRWT and EGFRT790M: Design, Semi-Synthesis, In Silico, and In Vitro Anticancer Studies

IF4.6

2022-09-0933

OAAI

Anti-cancer and immunomodulatory evaluation of new nicotinamide derivatives as potential VEGFR-2 inhibitors and apoptosis inducers: in vitro and in silico studies

JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY

IF5.4

2022-08-1832

OAAI

Design, Synthesis, Docking, DFT, MD Simulation Studies of a New Nicotinamide-Based Derivative: In Vitro Anticancer and VEGFR-2 Inhibitory Effects

一种新的基于烟酰胺的衍生物的设计，合成，对接，DFT，MD模拟研究: 体外抗癌和VEGFR-2抑制作用

IF4.6

2022-07-1994

OAAI

Design, Synthesis, In Silico and In Vitro Studies of New Immunomodulatory Anticancer Nicotinamide Derivatives Targeting VEGFR-2

IF4.6

2022-06-2415

OAAI

Discovery of new nicotinamides as apoptotic VEGFR-2 inhibitors: virtual screening, synthesis, anti-proliferative, immunomodulatory, ADMET, toxicity, and molecular dynamic simulation studies

JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY

IF5.4

2022-05-1638

OAAI